259 related articles for article (PubMed ID: 19423716)
1. Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma.
Innes AL; Carrington SD; Thornton DJ; Kirkham S; Rousseau K; Dougherty RH; Raymond WW; Caughey GH; Muller SJ; Fahy JV
Am J Respir Crit Care Med; 2009 Aug; 180(3):203-10. PubMed ID: 19423716
[TBL] [Abstract][Full Text] [Related]
2. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction.
Chillappagari S; Preuss J; Licht S; Müller C; Mahavadi P; Sarode G; Vogelmeier C; Guenther A; Nahrlich L; Rubin BK; Henke MO
Respir Res; 2015 Jul; 16(1):85. PubMed ID: 26169056
[TBL] [Abstract][Full Text] [Related]
3. MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma.
Welsh KG; Rousseau K; Fisher G; Bonser LR; Bradding P; Brightling CE; Thornton DJ; Gaillard EA
Chest; 2017 Oct; 152(4):771-779. PubMed ID: 28716644
[TBL] [Abstract][Full Text] [Related]
4. Mucins, mucus, and sputum.
Voynow JA; Rubin BK
Chest; 2009 Feb; 135(2):505-512. PubMed ID: 19201713
[TBL] [Abstract][Full Text] [Related]
5. A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation.
Chillappagari S; Müller C; Mahavadi P; Guenther A; Nährlich L; Rosenblum J; Rubin BK; Henke MO
J Cyst Fibros; 2016 May; 15(3):325-31. PubMed ID: 26526358
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
Henderson AG; Ehre C; Button B; Abdullah LH; Cai LH; Leigh MW; DeMaria GC; Matsui H; Donaldson SH; Davis CW; Sheehan JK; Boucher RC; Kesimer M
J Clin Invest; 2014 Jul; 124(7):3047-60. PubMed ID: 24892808
[TBL] [Abstract][Full Text] [Related]
7. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects.
Fahy JV; Steiger DJ; Liu J; Basbaum CB; Finkbeiner WE; Boushey HA
Am Rev Respir Dis; 1993 May; 147(5):1132-7. PubMed ID: 8484621
[TBL] [Abstract][Full Text] [Related]
8. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
[TBL] [Abstract][Full Text] [Related]
9. [Pathophysiology of chronic, bronchial hypersecretion (author's transl)].
Puchelle E; Girard F; Polu JM; Aug F; Sadoul P
Pathol Biol (Paris); 1978 Oct; 26(7):441-51. PubMed ID: 372900
[TBL] [Abstract][Full Text] [Related]
10. Analysis of respiratory mucus glycoproteins in asthma: a detailed study from a patient who died in status asthmaticus.
Sheehan JK; Richardson PS; Fung DC; Howard M; Thornton DJ
Am J Respir Cell Mol Biol; 1995 Dec; 13(6):748-56. PubMed ID: 7576713
[TBL] [Abstract][Full Text] [Related]
11. Gamma tocopherol-enriched supplement reduces sputum eosinophilia and endotoxin-induced sputum neutrophilia in volunteers with asthma.
Burbank AJ; Duran CG; Pan Y; Burns P; Jones S; Jiang Q; Yang C; Jenkins S; Wells H; Alexis N; Kesimer M; Bennett WD; Zhou H; Peden DB; Hernandez ML
J Allergy Clin Immunol; 2018 Apr; 141(4):1231-1238.e1. PubMed ID: 28736267
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology of chronic, bronchial hypersecretion (author's transl)].
Puchelle E; Girard F; Polu JM; Aug F; Sadoul P
Sem Hop; 1979 Feb 8-15; 55(5-6):273-83. PubMed ID: 219540
[TBL] [Abstract][Full Text] [Related]
13. TAILS proteomics reveals dynamic changes in airway proteolysis controlling protease activity and innate immunity during COPD exacerbations.
Mallia-Milanes B; Dufour A; Philp C; Solis N; Klein T; Fischer M; Bolton CE; Shapiro S; Overall CM; Johnson SR
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L1003-L1014. PubMed ID: 30284925
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil-mucus interplay in severe asthma: Implications for treatment with biologicals.
Venegas Garrido C; Mukherjee M; Svenningsen S; Nair P
Allergol Int; 2024 Jul; 73(3):351-361. PubMed ID: 38485545
[TBL] [Abstract][Full Text] [Related]
15. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
Henke MO; John G; Germann M; Lindemann H; Rubin BK
Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
[TBL] [Abstract][Full Text] [Related]
16. Physiology of airway mucus clearance.
Rubin BK
Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
[TBL] [Abstract][Full Text] [Related]
17. Airway Mucus Hyperconcentration in Non-Cystic Fibrosis Bronchiectasis.
Ramsey KA; Chen ACH; Radicioni G; Lourie R; Martin M; Broomfield A; Sheng YH; Hasnain SZ; Radford-Smith G; Simms LA; Burr L; Thornton DJ; Bowler SD; Livengood S; Ceppe A; Knowles MR; Noone PG; Donaldson SH; Hill DB; Ehre C; Button B; Alexis NE; Kesimer M; Boucher RC; McGuckin MA
Am J Respir Crit Care Med; 2020 Mar; 201(6):661-670. PubMed ID: 31765597
[No Abstract] [Full Text] [Related]
18. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.
Yuan S; Hollinger M; Lachowicz-Scroggins ME; Kerr SC; Dunican EM; Daniel BM; Ghosh S; Erzurum SC; Willard B; Hazen SL; Huang X; Carrington SD; Oscarson S; Fahy JV
Sci Transl Med; 2015 Feb; 7(276):276ra27. PubMed ID: 25717100
[TBL] [Abstract][Full Text] [Related]
19. CT and Functional MRI to Evaluate Airway Mucus in Severe Asthma.
Svenningsen S; Haider E; Boylan C; Mukherjee M; Eddy RL; Capaldi DPI; Parraga G; Nair P
Chest; 2019 Jun; 155(6):1178-1189. PubMed ID: 30910637
[TBL] [Abstract][Full Text] [Related]
20. Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.
Abrami M; Biasin A; Tescione F; Tierno D; Dapas B; Carbone A; Grassi G; Conese M; Di Gioia S; Larobina D; Grassi M
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
